Terry Dagnon serves as Executive at Outlook Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Terry Dagnon has executed 7 insider transactions totaling $847.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 20, 2023 involved selling 520,000 shares valued at $592.8K.
Terry Dagnon currently holds 653,058 shares of Outlook Therapeutics, Inc. (OTLK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Terry Dagnon has been a net seller of OTLK stock. They have purchased $59.5K and sold $788.5K worth of shares.
Terry Dagnon's most recent insider trade was on Apr 20, 2023, when they sold 520,000 shares at $1.14 per share.
Get notified when new Form 4 filings are submitted
| $1.05 |
| Discretionary |
| Dec 6, 2021 | OTLK | $34.8K | Purchase | 25,201 | $1.38 | Discretionary |
| Dec 3, 2021 | OTLK | $14.2K | Purchase | 10,000 | $1.42 | Discretionary |
| Feb 23, 2021 | OTLK | $33.2K | Sale | 15,900 | $2.09 | Discretionary |
| Feb 12, 2021 | OTLK | $162.4K | Sale | 63,700 | $2.55 | Discretionary |
| Mar 19, 2020 | OTLK | $0 | Award | 1,207,457 | $N/A | Discretionary |